Full analysis #GLP1 #EmployeeBenefits #HealthcareCosts #WorkforceHealth #Aon Farheen Dam Doug Melton Lisa Stevens Laura Rissover Liz Parr Lindsay Dower, MHA Kembre Roberts, PhD Workforce-Focused Analysis on GLP-1s: Phase Two Findings aon.com To view or add a comment, sign in Novo Nordisks FDA-approved Wegovy pill, as highlighted by Ferrin Williams, PharmD MBA, marks a major shift in obesity careintroducing an oral GLP-1 option that could expand access, improve adherence, and reshape how clinicians manage chronic weight conditions
If you receive a denial, you have the right to an appeal
Patients with a history of pancreatitis, for example, should be counseled about potential complications, medical studies show
The FTO rs9939609 variant also influences baseline appetite drive and weight-regaining capacity, meaning two patients on identical doses may experience different hunger signals
Patients who suspect their medication has been stored improperly should consult their healthcare provider or pharmacist before administration
Several Wellstar facilities will host eventsand you can be a part of the celebration